The Enterprise Value as of December 2025 (TTM) for CytomX Therapeutics, Inc. (CTMX) is 662.44M

According to CytomX Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 662.44M. This represents a change of 223.78% compared to the average of 204.60M of the last 4 quarters.

CytomX Therapeutics, Inc. (CTMX) Historical Enterprise Value (quarterly & annually)

How has CTMX Enterprise Value performed in the past?

The mean historical Enterprise Value of CytomX Therapeutics, Inc. over the last ten years is 250.06M. The current 662.44M Enterprise Value has changed 26.39% with respect to the historical average. Over the past ten years (40 quarters), CTMX's Enterprise Value was at its highest in in the March 2018 quarter at 957.38M. The Enterprise Value was at its lowest in in the December 2022 quarter at -69628126.40.

CytomX Therapeutics, Inc. (CTMX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of CytomX Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

CytomX Therapeutics, Inc. (CTMX) Average Enterprise Value

How has CTMX Enterprise Value performed in the past?

The current Enterprise Value of CytomX Therapeutics, Inc. (CTMX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

CytomX Therapeutics, Inc. (CTMX) Enterprise Value vs. Peers

How is CTMX’s Enterprise Value compared to its peers?

CytomX Therapeutics, Inc.’s Enterprise Value is less than Erasca, Inc. (888.32M), greater than Iovance Biotherapeutics, Inc. (650.41M), less than MBX Biosciences, Inc. Common Stock (803.43M), less than ArriVent BioPharma, Inc. Common Stock (892.49M), less than MeiraGTx Holdings plc (679.86M), less than Astria Therapeutics, Inc. (677.40M), less than MoonLake Immunotherapeutics (724.26M), less than Replimune Group, Inc. (804.93M), less than Ginkgo Bioworks Holdings, Inc. (815.10M), greater than Anavex Life Sciences Corp. (296.44M),

Build a custom stock screener for CytomX Therapeutics, Inc. (CTMX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CytomX Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

CytomX Therapeutics, Inc. (CTMX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like CytomX Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.